Lupin Receives FDA Approval for New Cholesterol Drug

Lupin has received an FDA approval for its cholesterol drug, Nikita Pitavastatin. The drug, which received a new drug approval from the agency, is poised as the latest treatment for patients suffering from primary hyperlipidemia or mixed dyslipidemia by lowering total...

Aum Cardiovascular Grabs FDA Node for Heart Monitoring Device

Aum Cardiovascular has secured FDA approval for its cardiovascular device, Cadance. The device, which is to be used in a primary care setting, applies an algorithm to the natural acoustics of the heart. This will allow doctors to adequately diagnose patients without...

Abiomed Reports Share Increase After Lower than Expected CMS Cuts

Abiomed has announced a rise in shares due to a less-than-expected CMS cut to reimbursements for the company’s heart pump, Impella. The Centers for Medicaid and Medicare Services initially proposed a 35% cut to reimbursement, but only 19% was actually implemented....

CRISPR Technology Reaches Breakthrough in Embryo Gene Editing

Scientists have reportedly successfully edited the genes of embryos to repair a serious disease mutation without damaging the embryos. The study, which was recently published in the journal, Nature, indicates a breakthrough in the biotechnology industry and hope for a...

FDA Previews Digital Health FastTrack Program

The FDA unveiled its program for digital health approvals this week. Named the Digital Health Innovation Action Plan, the program aims to speed up approval processes for digital health software which functions differently and poses a lower risk to health than medical...

Trump to Decide on Long Awaited Insurance Subsidies

President Trump has confirmed that he will decide whether to fund cost-sharing subsidies for lower-income Americans on Obamacare. The subsidies would offset high medical bills, enabling more Americans to afford their healthcare. A decision against funding the...